Related Experiment Video
Updated: Jul 16, 2026

04:33
Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder
Published on: April 26, 2024
Subtypes of depression in dementia
M Amore1, P Tagariello, C Laterza
1Dipartimento di Neuroscienze, Sezione di Psichiatria, Università di Parma, Strada del Quartiere 2/A, I-43100 Parma, Italy. mario.amore@unipr.it <mario.amore@unipr.it>
Archives of Gerontology and Geriatrics
|February 24, 2007
Summary
Depression is a common condition in Alzheimer
Area of Science:
- Neuropsychiatry
- Geriatric Psychiatry
- Neurology
Background:
- Depression is a frequent neuropsychiatric comorbidity in Alzheimer dementia (AD).
- Prevalence rates for depression in AD vary widely (0% to 87%) due to differences in study populations and assessment tools.
- Depressive symptoms in AD are often early-onset, persistent, and increase with dementia progression, significantly impacting quality of life and survival.
Purpose of the Study:
- To review the prevalence and impact of depression in Alzheimer dementia.
- To discuss the evolving clinical approaches to managing depression in AD patients.
Main Methods:
- Literature review of studies on depression in Alzheimer dementia.
- Analysis of prevalence rates and influencing factors.
- Discussion of clinical management strategies.
Main Results:
- Depression affects a significant portion of Alzheimer dementia patients.
- Depressive symptoms are associated with reduced quality of life and potentially shorter survival.
- Clinical approaches to managing depression in AD are evolving.
Conclusions:
- Depression is a critical comorbidity in Alzheimer dementia that requires attention.
- Effective treatment of depression may improve outcomes for AD patients.
- Further research into the interrelationships and optimal management strategies is warranted.
Related Concept Videos
Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
Depressive Disorders: MDD and Dysthymia
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Depression: Overview
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Depressive Disorders: Etiology
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...

